Literature DB >> 16030519

Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis.

R B Ceddia1.   

Abstract

In recent years, the adipose tissue has emerged as an important endocrine organ. It is now recognized that besides storing energy the adipocytes also secrete several bioactive peptides, collectively called adipocytokines. Among these adipocytokines, leptin, the product of the ob gene, has been extensively investigated over the last decade. Skeletal muscle and adipose tissue, two major tissues involved in the regulation of glucose and fatty acids metabolism, have been consistently demonstrated to be directly affected by leptin. By binding to its receptors located in skeletal muscle and fat cells, leptin promotes energy dissipation and prevents fatty acid accumulation and 'lipotoxicity' in these tissues. On the other hand, under conditions of peripheral leptin resistance, such as observed in obese humans, the activation of pathways involved in fatty acid oxidation may be impaired. This leads to intracellular accumulation of lipid intermediates and causes insulin resistance. This review examines the metabolic pathways that are directly activated by leptin and how it regulates glucose and fatty acids metabolism in skeletal muscle and fat tissue. Furthermore, the impact of peripheral leptin resistance in these tissues leading to dysfunctional metabolic adaptations is also discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16030519     DOI: 10.1038/sj.ijo.0803025

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  51 in total

Review 1.  Lipodystrophy: pathophysiology and advances in treatment.

Authors:  Christina G Fiorenza; Sharon H Chou; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

2.  The host response to poly(lactide-co-glycolide) scaffolds protects mice from diet induced obesity and glucose intolerance.

Authors:  Michael A Hendley; Kendall P Murphy; Christopher Isely; Heather L Struckman; Prakasam Annamalai; R Michael Gower
Journal:  Biomaterials       Date:  2019-06-19       Impact factor: 12.479

Review 3.  Counterregulation of insulin by leptin as key component of autonomic regulation of body weight.

Authors:  Katarina T Borer
Journal:  World J Diabetes       Date:  2014-10-15

4.  Leptin signaling: A key pathway in immune responses.

Authors:  Claudio Procaccini; Elaine V Lourenco; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Signal Transduct Ther       Date:  2009-01-01

5.  Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients.

Authors:  Gilberto Paz-Filho; Karin Esposito; Barry Hurwitz; Anil Sharma; Chuanhui Dong; Victor Andreev; Tuncay Delibasi; Halil Erol; Alejandro Ayala; Ma-Li Wong; Julio Licinio
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

Review 6.  Leptin Signaling in the Control of Metabolism and Appetite: Lessons from Animal Models.

Authors:  Alberto A Barrios-Correa; José A Estrada; Irazú Contreras
Journal:  J Mol Neurosci       Date:  2018-10-03       Impact factor: 3.444

Review 7.  Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment.

Authors:  Seong Lin Teoh; Srijit Das
Journal:  Tumour Biol       Date:  2016-09-14

8.  Leptin administration downregulates the increased expression levels of genes related to oxidative stress and inflammation in the skeletal muscle of ob/ob mice.

Authors:  Neira Sáinz; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Mediators Inflamm       Date:  2010-06-30       Impact factor: 4.711

Review 9.  The procognitive effects of leptin in the brain and their clinical implications.

Authors:  G Paz-Filho; M-L Wong; J Licinio
Journal:  Int J Clin Pract       Date:  2010-12       Impact factor: 2.503

10.  Histological evaluation of AMPK signalling in primary breast cancer.

Authors:  Sirwan M Hadad; Lee Baker; Philip R Quinlan; Katherine E Robertson; Susan E Bray; George Thomson; David Kellock; Lee B Jordan; Colin A Purdie; David G Hardie; Stewart Fleming; Alastair M Thompson
Journal:  BMC Cancer       Date:  2009-09-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.